Their suite of products are specifically targeted at biomarker testing and infectious disease research and designed to facilitate the transition to personalized medicine.
Axela, Inc. (previously Axela Biosensors, Inc.) was spun out of the University of Toronto in 2001 to commercialize diffractive optics technology. Their flow-through platforms use the robust technologies of flow-through microarrays and diffractive optics sensors. In 2006, the company launched its first commercial system, the dotLab, for real-time protein interaction analysis. In 2008, the company was recognized as one of Canada’s Top 10 Life Science Companies followed in 2010 by The Biotechnology Initiative (TBI) Company of the Year Award. The expanded Axela provides powerful approaches to DNA, RNA, and protein analysis that have the potential to revolutionize multiplex biomarker testing in clinical research and diagnostics.
Business Type: Nanotextile » | Biotechnology » | Electrotechnics » |
50 Ronson Drive, Suite 105
M9W 1B3 Toronto
Phone: (416) 798-1625 Option 3
Share with friends:
Next companies in category